logo
Plus   Neg
Share
Email

AstraZeneca: FDA Issues Complete Response Letter On SNDA For Farxiga - Quick Facts

AstraZeneca plc (AZN.L,AZN) received a complete response letter from the US FDA with respect to the supplemental New Drug Application for Farxiga (dapagliflozin) filed by the company as an adjunct treatment to insulin to improve glycaemic control in adult patients with type-1 diabetes.

Farxiga (dapagliflozin) is an oral, once-daily selective inhibitor of SGLT2 indicated as both monotherapy and as part of combination therapy to improve glycaemic control as an adjunct to diet and exercise in adults with type-1 diabetes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Whole Foods Market stores have recalled Decorated Red Apple Cookies as they may contain undeclared egg. People who have an allergy or severe sensitivity to these allergens run the risk of serious or life-threatening allergic reaction if they consume these products. The cookies were sold by the... Norwex has announced voluntary recall of about 58,000 rubber brooms due to laceration hazard. According to the company, handles of the recalled brooms can break in half, exposing a metal inner rim, posing a laceration hazard to the user. The recall involves extendable indoor/outdoor white rubber... Amazon.com Inc. has expanded its AmazonFresh grocery delivery service to three new cities. Beginning today, Amazon Prime members in Houston, Minneapolis and Phoenix can shop thousands of products, ranging from meat and seafood to fresh produce and everyday essentials. The groceries will be delivered to their homes in two hours or less, with options for one-hour and two-hour delivery.
Follow RTT